Your browser doesn't support javascript.
loading
Optimizing panel-based tumor mutational burden (TMB) measurement.
Budczies, J; Allgäuer, M; Litchfield, K; Rempel, E; Christopoulos, P; Kazdal, D; Endris, V; Thomas, M; Fröhling, S; Peters, S; Swanton, C; Schirmacher, P; Stenzinger, A.
Afiliación
  • Budczies J; Institute of Pathology, University Hospital Heidelberg, Heidelberg; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany. Electronic address: jan.budczies@med.uni-heidelberg.de.
  • Allgäuer M; Institute of Pathology, University Hospital Heidelberg, Heidelberg.
  • Litchfield K; Cancer Evolution and Genome Instability Translational Cancer Therapeutics Laboratory, Francis Crick Institute, London, UK.
  • Rempel E; Institute of Pathology, University Hospital Heidelberg, Heidelberg.
  • Christopoulos P; Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital, Heidelberg; German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg.
  • Kazdal D; Institute of Pathology, University Hospital Heidelberg, Heidelberg; German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg.
  • Endris V; Institute of Pathology, University Hospital Heidelberg, Heidelberg.
  • Thomas M; Department of Thoracic Oncology, Thoraxklinik at Heidelberg University Hospital, Heidelberg; German Center for Lung Research (DZL), Translational Lung Research Center Heidelberg (TLRC-H), Heidelberg.
  • Fröhling S; Department of Translational Oncology, National Center for Tumor Diseases (NCT), Heidelberg; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV), Lausanne University, Switzerland.
  • Swanton C; Cancer Evolution and Genome Instability Translational Cancer Therapeutics Laboratory, Francis Crick Institute, London, UK.
  • Schirmacher P; Institute of Pathology, University Hospital Heidelberg, Heidelberg; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany.
  • Stenzinger A; Institute of Pathology, University Hospital Heidelberg, Heidelberg; German Cancer Consortium (DKTK), Partner Site Heidelberg, Heidelberg, Germany. Electronic address: albrecht.stenzinger@med.uni-heidelberg.de.
Ann Oncol ; 30(9): 1496-1506, 2019 09 01.
Article en En | MEDLINE | ID: mdl-31268125
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Carga Tumoral / Mutación / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Carga Tumoral / Mutación / Neoplasias Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Ann Oncol Asunto de la revista: NEOPLASIAS Año: 2019 Tipo del documento: Article Pais de publicación: Reino Unido